| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 8e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |